Volume | 3,097 |
|
|||||
News | - | ||||||
Day High | 5.30 | Low High |
|||||
Day Low | 5.10 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Creative Medical Technology Holdings Inc | CELZ | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
5.20 | 5.10 | 5.30 | 5.15 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
37 | 3,097 | US$ 5.19 | US$ 16,068 | - | 3.93 - 13.30 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
10:38:50 | 15 | US$ 5.11 | USD |
Creative Medical Technology Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.33M | 1.38M | - | 89k | -10.14M | -7.34 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Creative Medical Technol... News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CELZ Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 5.41 | 5.815 | 5.0002 | 5.22 | 25,188 | -0.11 | -2.03% |
1 Month | 4.41 | 10.2812 | 4.00 | 5.83 | 633,459 | 0.89 | 20.18% |
3 Months | 4.67 | 10.2812 | 3.93 | 5.81 | 221,798 | 0.63 | 13.49% |
6 Months | 5.41 | 10.2812 | 3.93 | 5.74 | 108,830 | -0.11 | -2.03% |
1 Year | 5.30 | 13.30 | 3.93 | 7.78 | 526,058 | 0.00 | 0.00% |
3 Years | 32.00 | 51.45 | 3.30 | 20.19 | 1,400,195 | -26.70 | -83.44% |
5 Years | 32.00 | 51.45 | 3.30 | 20.19 | 1,400,195 | -26.70 | -83.44% |
Creative Medical Technol... Description
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues. |